Gazing into the crystal ball: Future considerations for ensuring sustained growth of the functional food and nutraceutical marketplace

Nutrition Research Reviews

Volumn 26, Issue 1, 2013, Pages 12-21

  Marinangeli, Christopher P F ^a   Jones, Peter J H ^b  

^a Kellogg Canada Inc   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Drugs; Functional foods; Nutraceuticals; Policy; Regulatory agencies

Indexed keywords

NUTRACEUTICAL;

ARTICLE; CONSUMER; DRUG INDUSTRY; FOOD INDUSTRY; FUNCTIONAL FOOD; HUMAN; NUTRIENT; CONSUMER ATTITUDE; DIET SUPPLEMENTATION; ECONOMICS; GOVERNMENT; HEALTH PROMOTION; LAW; LEGISLATION AND JURISPRUDENCE; NUTRITIONAL REQUIREMENT; TRENDS;

CONSUMER BEHAVIOR; DIETARY SUPPLEMENTS; FOOD INDUSTRY; FUNCTIONAL FOOD; GOVERNMENT; HEALTH PROMOTION; HUMANS; LEGISLATION, FOOD; NUTRITIONAL REQUIREMENTS;

EID: 84877956101     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422412000236     Document Type: Article

References (67)

1. Agriculture and Agri-food Canada (2009) What are functional foods and nutraceuticals? http://www4.agr.gc.ca/AAFC-AAC/ display-afficher.do? id1171305207040&langeng (accessed 25 September 2011).
2. Tapsell LC, Williams P, Droulez V, et al (2005) Functional Foods for the Australian Industry: Definitions and Opportunities. Wollongong: National Centre of Excellence in Functional Foods.
3. Blandon J, Cranfield J & Herson S (2007) Global market for functional foods and supplements. In Functional Food and Natural Health Product Issues: The Canadian and World Context. InFERG Working Paper no. 18. Guelph: International Food Economy Research Group, University of Guelph.
4. Blandon J, Cranfield J & Herson S (2007) Market share of functional foods and natural health products by sales, 2003. In Functional Food and Natural Health Product Issues: The Canadian and World Context. InFERG Working Paper no. 18. Guelph: International Food Economy Research Group, University of Guelph.
5. Martin FP, Rezzi S, Pere-Trepat E, et al. (2009) Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects. J Proteome Res 8, 5568-5579.
6. Rideout TC, Chan YM, Harding SV, et al. (2009) Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studies. Lipids Health Dis 8, 45.
7. Guillemard E, Tondu F, Lacoin F, et al. (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103, 58-68.
8. Harding SV, Zhao HL, Marinangeli CP, et al. (2009) Red algal cellular biomass lowers circulating cholesterol concentrations in Syrian golden hamsters consuming hypercholesterolaemic diets. Br J Nutr 102, 842-847.
9. Philippe D, Favre L, Foata F, et al. (2011) Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World J Gastroenterol 17, 459-469.
10. De Bruin EA, Rowson MJ, Van Buren, et al. (2011) Black tea improves attention and self-reported alertness. Appetite 56, 235-240.
11. Weaver CM & Liebman M (2002) Biomarkers of bone health appropriate for evaluating functional foods designed to reduce risk of osteoporosis. Br J Nutr 88, Suppl. 2, S225-S232.
12. Davidson MH (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, 27i-33i.
13. Atkinson AJ, Magnuson WG, Colburn WA, et al. (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69, 89-95.
14. Oozeer R, Rescigno M, Ross RP, et al. (2010) Gut health: predictive biomarkers for preventive medicine and development of functional foods. Br J Nutr 103, 1539-1544.
15. Puglisi MJ & Fernandez ML (2008) Modulation of C-reactive protein, tumor necrosis factor-a, and adiponectin by diet, exercise, and weight loss. J Nutr 138, 2293-2296.
16. Marinangeli CP & Jones PJ (2010) Plant sterols, marinederived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia. Nutr Metab (Lond) 7, 76.
17. Marinangeli CP & Jones PJ (2010) Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome. Ann Med 42, 317-333.
18. Yamada K, Sato-Mito N, Nagata J, et al. (2008) Health claim evidence requirements in Japan. J Nutr 138, 1192S-1198S.
19. European Food and Safety Agency (2011) Claims on disease risk reduction and child development or health under Article 14. http://www.efsa.europa.eu/en/ topics/topic/article14. htm (accessed 22 January 2012).
20. European Commission (2012) EU Register on nutrition and health claims. http://ec.europa.eu/nuhclaims/?eventsearch &CFID169885& CFTOKEN77733dc16b564cec-8B974E68- A55E-BCBD- 81A1575D7393A10C&jsessionid93121b711 d2370b2022b8045d657a69522a4TR
21. US Food and Drug Administration (2003) Claims that can be made for conventional foods and dietary supplements. http://www.fda.gov/food/ labelingnutrition/labelclaims/ucm 111447.htm (accessed 21 February 2011).
22. US Food and Drug Administration (2009) Guidance for industry: a food labeling guide: appendix C - health claims. http://www.fda.gov/Food/ GuidanceComplianceRegulatory Information/GuidanceDocuments/ FoodLabelingNutrition/ FoodLabelingGuide/ucm064919.htm (accessed 21 February 2011).
23. Hasler CM (2008) Health claims in the United States: an aid to the public or a source of confusion? J Nutr 138, 1216S-1220S.
24. US Food and Drug Administration (2011)Summary of qualified health claims subject to enforcement discretion. http://www. fda.gov/Food/LabelingNutrition/ LabelClaims/Qualified HealthClaims/ucm073992.htm (accessed 22 January 2012).
25. Food Standards Australia New Zealand (2012) Call for submissions - proposal P293: nutrition, health and related claims, vol. 4-12. Canberra and Wellington: Food Standards Australia New Zealand.
26. Health Canada (2010) Health claim assessments. http://www. hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/assess-evalu/ index-eng.php (accessed 11 July 2012).
27. LAbbe MR, Dumais L, Chao E, et al. (2008) Health claims on foods in Canada. J Nutr 138, 1221S-1227S.
28. Tapsell LC (2008) Evidence for health claims: a perspective from the Australia-New Zealand region. J Nutr 138, 1206S-1209S.
29. Yang Y (2008) Scientific substantiation of functional food health claims in China. J Nutr 138, 1199S-1205S.
30. European Commission (2007) Corrigendum to regulation (EC) no. 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. In Official Journal of the European Union, pp. L12/3-L12/18. Brussels: Publications Office.
31. Marinangeli CP & Jones PJ (2011) Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects. Br J Nutr 105, 110-117.
32. Marinangeli CP, Kassis AN & Jones PJ (2009) Glycemic responses and sensory characteristics of whole yellow pea flour added to novel functional foods. J Food Sci 74, S385-S389.
33. Dieroff C (2011) Beverage trends: consumers want it all. In Prepared Foods, vol. February, pp. 49-55. Deerfield, IL: Business News Publishing Co.
34. Cox DN, Evans G & Lease HJ (2011) The influence of product attributes, consumer attitudes and characteristics on the acceptance of: (1) novel bread and milk, and dietary supplements and (2) fish and novel meats as dietary vehicles of long chain omega 3 fatty acids. Food Qual Preference 22, 205-212.
35. Olsen AK & Whalen MD (2009) Public perceptions of the pharmaceutical industry and drug safety: implications for the pharmacovigilance professional and the culture of safety. Drug Saf 32, 805-810.
36. Biltekoff C (2010) Consumer response: the paradoxes of food and health. Ann N Y Acad Sci 1190, 174-178.
37. Grunert KG (2010) European consumersacceptance of functional foods. Ann N Y Acad Sci 1190, 166-173.
38. Health Canada (2001) Health Canada scientific summary on the U.S. health claim on fibre-containing grain products, fruits and vegetables and cancer. http://www.hc-sc.gc.ca/ fn-an/label-etiquet/claims-reclam/assess-evalu/fibre- cancereng. php (accessed 22 January 2012).
39. Chicago Dietetic Association, South Suburban Dietetic Association (Ill.) & Dietitians of Canada (2000) Manual of Clinical Dietetics, 6th ed. Chicago, IL: American Dietetic Association.
40. Starling S (2011) EU researchers revolted as EFSA clears health claims vault. http://www.nutraingredients.com/ Regulation/EU-researchers-revolted-as- EFSA-clears-health- claims-vault (accessed 2 October 2011).
41. Biesalski HK, Aggett PJ, Anton R, et al. (2011) 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition. Nutrition 27, S1-S20.
42. Starling S (2011) NDA panellist: angry academics would come to same conclusions if on our panel. http://www. nutraingredients.com/Regulation/NDA- panellist-Angry-academics- would-come-to-same-conclusions-if-on-our-panel (accessed 2 October 2011).
43. Codex Alimentarius (1997) Guidelines for Use of Nutrition and Health Claims, CAC/GL 23-1997. Rome: Codex Alimentarius.
44. Daniells S (2008) IADSA keeps pressure on Codex over science for health claims. http://www.nutraingredients. com/Regulation/IADSA-keeps-pressure-on- Codex-over-science- for-health-claims (accessed 11 September 2011).
45. Florentino RF (1997) The ILSI SEA Regional Forum and Workshop on recommended dietary allowances: scientific basis and future directions. Asia Pac J Clin Nutr 7, 96-101.
46. Barba CV & Cabrera MI (2008) Recommended dietary allowances harmonization in Southeast Asia. Asia Pac J Clin Nutr 17, Suppl. 2, 405-408.
47. Demonty I, Chan YM, Pelled D, et al. (2006) Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr 84, 1534-1542.
48. Ebine N, Jia X, Demonty I, et al. (2005) Effects of a water-soluble phytostanol ester on plasma cholesterol levels and red blood cell fragility in hamsters. Lipids 40, 175-180.
49. Ebine N, Demonty I, Jia X, et al. (2006) Plant stanol ascorbate esters reduce body weight gain through decreased energy absorption in hamsters. Int J Obes (Lond) 30, 751-757.
50. Macfarlane GT, Furrie E & Macfarlane S (2004) Bacterial milieu and mucosal bacteria in ulcerative colitis. Novartis Found Symp 263, 57-70, 211-218.
51. Negroni A, Costanzo M, Vitali R, et al. (2012) Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 18, 913-924.
52. Ott SJ, Musfeldt M, Wenderoth DF, et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693.
53. Sepehri S, Kotlowski R, Bernstein CN, et al. (2007) Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis 13, 675-683.
54. Jew S, AbuMweis SS & Jones PJ (2009) Evolution of the human diet: linking our ancestral diet to modern functional foods as a means of chronic disease prevention. J Med Food 12, 925-934.
55. Otten JJ, Hellwig JP & Meyers LD (2006) Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, DC: National Academies Press.
56. Hussein N, Ah-Sing E, Wilkinson P, et al. (2005) Long-chain conversion of [13C]linoleic acid and a-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 46, 269-280.
57. Cunnane SC, Plourde M, Stewart K, et al. (2007) Docosahexaenoic acid and shore-based diets in hominin encephalization: a rebuttal. Am J Hum Biol 19, 578-581.
58. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30.
59. Simopoulos AP (2002) Omega-3 fatty acids and cardiovascular disease: the epidemiological evidence. Environ Health Prev Med 6, 203-209.
60. Simopoulos AP (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60, 502-507.
61. Elmadfa I & Kornsteiner M (2009) Dietary fat intake - a global perspective. Ann Nutr Metab 54, Suppl. 1, 8-14.
62. Abumweis SS, Barake R & Jones PJ (2008) Plant sterols/ stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 52, 1811.
63. Demonty I, Ras RT, van der Knaap HC, et al. (2009) Continuous dose-response relationship of the LDL-cholesterollowering effect of phytosterol intake. J Nutr 139, 271-284.
64. Berger A, Jones PJ & Abumweis SS (2004) Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis 3, 5.
65. Jenkins DJ, Kendall CW, Marchie A, et al. (2003) The Garden of Eden - plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol A Mol Integr Physiol 136, 141-151.
66. Jenkins DJ & Kendall CW (2006) The garden of Eden: plantbased diets, the genetic drive to store fat and conserve cholesterol, and implications for epidemiology in the 21st century. Epidemiology 17, 128-130.
67. Plat J, Nichols JA & Mensink RP (2005) Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J Lipid Res 46, 2468-2476.